Modulate Bio Inc.
PrivateLast Round
Seed
Jun 12, 2025
Total Funding Raised
$1.66M
Company Overview
Modulate Bio Inc. operates in Healthcare & Life Sciences and is based in Massachusetts. Its latest recorded funding round was a Seed round in June 2025.
Modulate Bio Inc. is a biotechnology company developing novel, differentiated GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, and anxiety.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Modulate Bio Inc. Comparables
Compare Modulate Bio Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gabather AB | 78% | |
| AgeneBio, Inc. | 77% | |
| AtaiBeckley Inc. | 76% |
For institutional investors. Book with your work email.
Modulate Bio Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 12, 2025 | ||||
| Pre Seed | Oct 23, 2024 | ||||
| Seed Round | Feb 11, 2024 | ||||
| Grant | Jan 1, 2024 | ||||
| Accelerator | Dec 13, 2023 | ||||
Grant | Sep 26, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Modulate Bio Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bija Ventures | Seed Round, Seed |
| Harvard Innovation Labs | Grant |
| Pillar VC | Seed Round, Accelerator, Pre Seed, Seed |
| Blavatnik Fellowship in Life Science Entrepreneurship | Grant |
| Novaterra | Seed Round, Pre Seed, Seed |
| Nucleate | Accelerator |
| Phoenix Investment Club | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 856% MoM, from 131 to 1.3K.
- Jun 12, 2025
$660K raised in Seed round.
For institutional investors. Book with your work email.
Modulate Bio Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Modulate Bio Inc.'s valuation, stock price, and market status.
Is Modulate Bio Inc. a public or private company?
Modulate Bio Inc. is a private company.
What is the current stock price of Modulate Bio Inc.?
Modulate Bio Inc. is a private company, so its shares have no public market price. Caplight tracks Modulate Bio Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Modulate Bio Inc. worth (valuation)?
Valuation information for Modulate Bio Inc. is not publicly available.
Can I buy Modulate Bio Inc. stock?
Modulate Bio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Modulate Bio Inc.'s last funding round?
Modulate Bio Inc.'s most recent funding round was Seed on June 12, 2025.
Who are the main investors in Modulate Bio Inc.?
Key investors in Modulate Bio Inc. include Bija Ventures, Harvard Innovation Labs, Pillar VC, Blavatnik Fellowship in Life Science Entrepreneurship, Novaterra.
Will Modulate Bio Inc. IPO soon?
No public IPO plans have been announced for Modulate Bio Inc..
How can I track Modulate Bio Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Modulate Bio Inc.'s shares on secondary markets.